RGC compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name

RGCRegencell Bioscience Holdings Ltd

Mkt capRevenueRevenue

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RGCRegencell Bioscience Holdings Ltd

DFTXDefinium Therapeutics, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

RGC

No earnings history for RGC.

DFTX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.9%0.00%×0.00

May 8 '26±9.7%▼−4.96%×0.52

Q1 FY26±12.9%▲+0.93%×0.07

Jan 12 '26—▲+0.29%—

= impliedRGC realized, solidDFTX realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedSource: market data

RGCRegencell Bioscience Holdings Ltd

6.30▲+0.13%· post 6.21

Mkt cap$3.1B

DFTXDefinium Therapeutics, Inc.

33.36▲+2.75%· post 33.47

ClosedNov 3 '26

Mkt cap$4.4B

Compare

ClosedNov 3 '26

RGCRegencell Bioscience Holdings Ltd

DFTXDefinium Therapeutics, Inc.

6.30▲+0.13%post 6.21

Price

33.36▲+2.75%post 33.47

$3.1B

Mkt cap

$4.4B

RGC6.30▲+0.13%vsDFTX33.36▲+2.75%ClosedNov 3 '26